Enhabit, Inc. (NYSE:EHAB) Receives $8.75 Consensus PT from Analysts

Enhabit, Inc. (NYSE:EHAB - Get Free Report) has been given a consensus rating of "Hold" by the six analysts that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $8.75.

Several analysts have recently weighed in on the stock. Jefferies Financial Group raised shares of Enhabit from a "hold" rating to a "buy" rating and increased their price target for the company from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners reiterated a "market perform" rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th.

Enhabit Trading Up 1.4 %

Enhabit stock traded up $0.11 during trading on Wednesday, reaching $7.82. 254,468 shares of the company were exchanged, compared to its average volume of 257,754. The stock's 50 day simple moving average is $7.78 and its two-hundred day simple moving average is $8.15. The company has a market capitalization of $393.22 million, a P/E ratio of -3.37 and a beta of 1.82. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to analysts' expectations of $261.69 million. During the same quarter in the prior year, the firm earned $0.03 EPS. On average, equities research analysts expect that Enhabit will post 0.22 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Jeffrey Bolton acquired 4,000 shares of the firm's stock in a transaction dated Thursday, December 12th. The stock was acquired at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares of the company's stock, valued at $852,871.36. This represents a 4.25 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stuart M. Mcguigan acquired 15,000 shares of the stock in a transaction dated Tuesday, December 10th. The shares were bought at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the transaction, the director now owns 46,810 shares of the company's stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.90% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Franklin Resources Inc. grew its position in shares of Enhabit by 19.6% in the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company's stock valued at $256,000 after buying an additional 5,317 shares during the last quarter. WINTON GROUP Ltd acquired a new position in Enhabit in the second quarter valued at $955,000. Marshall Wace LLP acquired a new stake in shares of Enhabit during the second quarter worth about $1,941,000. Systematic Financial Management LP increased its position in shares of Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company's stock worth $14,522,000 after purchasing an additional 199,235 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Enhabit in the 3rd quarter valued at about $215,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.